205 related articles for article (PubMed ID: 23990164)
1. Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment.
Fiaccadori E; Regolisti G; Cademartiri C; Cabassi A; Picetti E; Barbagallo M; Gherli T; Castellano G; Morabito S; Maggiore U
Clin J Am Soc Nephrol; 2013 Oct; 8(10):1670-8. PubMed ID: 23990164
[TBL] [Abstract][Full Text] [Related]
2. [The safety and efficacy of regional citrate anticoagulation in sustained low efficiency dialysis].
Zhang L; Wang TL; Zhao YL; Chen ZW; Tang Y; Yang YY; Liao YJ; Fu P
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):459-63. PubMed ID: 24059990
[TBL] [Abstract][Full Text] [Related]
3. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
Finkel KW; Foringer JR
Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
[TBL] [Abstract][Full Text] [Related]
4. A novel citrate-based protocol versus heparin anticoagulation for sustained low-efficiency dialysis in the ICU: safety, efficacy, and cost.
Wen M; Küchle C; Steubl D; Satanovskji R; Heemann U; Suttmann Y; Angermann S; Kemmner S; Rehbehn L; Huber M; Hauser C; Schmaderer C; Reichelt AL; Haller B; Renders L
BMC Nephrol; 2018 Apr; 19(1):79. PubMed ID: 29614970
[TBL] [Abstract][Full Text] [Related]
5. Automated regional citrate anticoagulation: technological barriers and possible solutions.
Szamosfalvi B; Frinak S; Yee J
Blood Purif; 2010; 29(2):204-9. PubMed ID: 20093828
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Regional Anticoagulation with 4% Trisodium Citrate Versus Heparin in Extended Hemodialysis among Critical Patients with Cancer and Acute Kidney Injury.
Moura EIM; de Brito GA; Alves JA; Imanishe MH; Baptista AL; Andrade LAS; Pereira BJ
Blood Purif; 2021; 50(1):50-56. PubMed ID: 32388506
[TBL] [Abstract][Full Text] [Related]
7. Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure.
Schneider M; Liefeldt L; Slowinski T; Peters H; Neumayer HH; Morgera S
Int J Artif Organs; 2008 Jan; 31(1):43-8. PubMed ID: 18286453
[TBL] [Abstract][Full Text] [Related]
8. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
[TBL] [Abstract][Full Text] [Related]
9. Sustained low-efficiency dialysis with regional citrate anticoagulation in medical intensive care unit patients with liver failure: A prospective study.
Lahmer T; Messer M; Rasch S; Beitz A; Schnappauf C; Schmid RM; Huber W
J Crit Care; 2015 Oct; 30(5):1096-100. PubMed ID: 26254678
[TBL] [Abstract][Full Text] [Related]
10. Sustained low-efficiency extended dialysis (SLED) with single-pass batch system in critically-ill patients with acute kidney injury (AKI).
Caires RA; Abdulkader RCRM; Costa E Silva VT; Ferreira GS; Burdmann EA; Yu L; Macedo E
J Nephrol; 2016 Jun; 29(3):401-409. PubMed ID: 26298845
[TBL] [Abstract][Full Text] [Related]
11. Sustained low-efficiency dialysis with regional citrate anticoagulation in critically ill patients with COVID-19 associated AKI: A pilot study.
Di Mario F; Regolisti G; Di Maria A; Parmigiani A; Benigno GD; Picetti E; Barbagallo M; Greco P; Maccari C; Fiaccadori E
J Crit Care; 2021 Jun; 63():22-25. PubMed ID: 33611151
[TBL] [Abstract][Full Text] [Related]
12. Hypophosphatemia in critically ill patients undergoing Sustained Low-Efficiency Dialysis with standard dialysis solutions.
Di Mario F; Regolisti G; Maggiore U; Pacchiarini MC; Menegazzo B; Greco P; Maccari C; Zambrano C; Cantarelli C; Pistolesi V; Morabito S; Fiaccadori E
Nephrol Dial Transplant; 2022 Nov; 37(12):2505-2513. PubMed ID: 35481705
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the application of regional citrate anticoagulation in sustained low efficiency hemodialysis].
Wang T; Zhang L; Chen Z; Fu P
Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):953-6. PubMed ID: 25623561
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of regional citrate anticoagulation during 8-hour sustained low-efficiency dialysis.
Clark JA; Schulman G; Golper TA
Clin J Am Soc Nephrol; 2008 May; 3(3):736-42. PubMed ID: 18272829
[TBL] [Abstract][Full Text] [Related]
15. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
[TBL] [Abstract][Full Text] [Related]
16. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
Wright S; Steinwandel U; Ferrari P
Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
[TBL] [Abstract][Full Text] [Related]
17. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal.
Berbece AN; Richardson RM
Kidney Int; 2006 Sep; 70(5):963-8. PubMed ID: 16850023
[TBL] [Abstract][Full Text] [Related]
18. Regional citrate anticoagulation during simulated treatments of sustained low efficiency diafiltration.
Marshall MR; Ma TM; Eggleton K; Ferencz A
Nephrology (Carlton); 2003 Dec; 8(6):302-10. PubMed ID: 15012701
[TBL] [Abstract][Full Text] [Related]
19. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
Ong SC; Wille KM; Speer R; Tolwani AJ
Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309
[TBL] [Abstract][Full Text] [Related]
20. Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.
Buturović-Ponikvar J; Gubensek J; Ponikvar R
Ther Apher Dial; 2005 Jun; 9(3):237-40. PubMed ID: 15966997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
